The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

0.2%Dividend Yield

Oct 26

$0.07

Jul 26

$0.10

Mar 26

$0.08

Jan 26

$0.08

Oct 25

$0.07

10Y Growth

N/A

5Y Growth

7.33%

3Y Growth

2.03%

1Y Growth

N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF, includes biotech companies that could overlap with VIRS's investments in biothreat prevention and treatment.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF, offers broad exposure to the biotech sector, including companies that may work on biothreat solutions.

iShares Biotechnology

IBB

Mkt Cap0

iShares Biotechnology ETF, covers biotech firms that could be involved in developing treatments or vaccines for biothreats.

Principal Healthcare Innovators Index

BTEC

Mkt Cap0

Principal Healthcare Innovators Index ETF, focuses on early-stage healthcare innovation, potentially including biothreat mitigation technologies.

iShares Genomics Immunology and Healthcare

IDNA

Mkt Cap0

iShares Genomics Immunology and Healthcare ETF, invests in companies that could be at the forefront of addressing biothreats through advanced medical research.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund, includes biotech companies that may engage in biothreat response efforts.

Invesco Biotechnology & Genome

PBE

Mkt Cap0

Invesco Dynamic Biotechnology & Genome ETF, targets biotech and genome companies, some of which may focus on biothreats.

Global X Genomics & Biotechnology

GNOM

Mkt Cap0

Global X Genomics & Biotechnology ETF, focuses on genomics and biotech, sectors crucial for developing biothreat countermeasures.

ARK Genomic Revolution

ARKG

Mkt Cap0

ARK Genomic Revolution ETF, invests in companies across genomics, including those potentially involved in combating biothreats.

Holdings

Regions

Sectors

About

Miscellaneous

Investment Trusts/Mutual Funds

The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. The Advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. It is non-diversified.

CEO

Country

United States

ISIN

US69374H7585

Listings

0 Comments

Share your thoughts

FAQ

What is Pacer BioThreat Strategy stock price today?▼

The current price of VIRS is $39.96 USD — it has decreased by -0.14% in the past 24 hours. Watch Pacer BioThreat Strategy stock price performance more closely on the chart.

What is Pacer BioThreat Strategy stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on BATS exchange Pacer BioThreat Strategy stocks are traded under the ticker VIRS.

Does Pacer BioThreat Strategy pay dividends?▼

Yes, VIRS dividends are paid quarterly. The last dividend per share was 0.1 . As of today, Dividend Yield (FWD)% is 0.2%.

In which sector is Pacer BioThreat Strategy located?▼

Pacer BioThreat Strategy operates in the Other sector.

When did Pacer BioThreat Strategy complete a stock split?▼

Pacer BioThreat Strategy has not had any recent stock splits.